Loading...
BP8 logo

BPH Global LtdASX:BP8 Stock Report

Market Cap AU$4.7m
Share Price
AU$0.002
My Fair Value
n/a
1Y-33.3%
7D0%
Portfolio Value
View

BPH Global Ltd

ASX:BP8 Stock Report

Market Cap: AU$4.7m

BPH Global (BP8) Stock Overview

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. More details

BP8 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

BP8 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Community Contributor
US$21.53FV 66.1% undervalued intrinsic discount
5419.8%Revenue growth p.a.
6.1k
18
0
121
3mo ago

BPH Global Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for BPH Global
Historical stock prices
Current Share PriceAU$0.002
52 Week HighAU$0.003
52 Week LowAU$0.001
Beta0.50
1 Month Change0%
3 Month Change0%
1 Year Change-33.33%
3 Year Change-92.00%
5 Year Change-97.89%
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholder Returns

BP8AU BiotechsAU Market
7D0%-4.5%-1.7%
1Y-33.3%-43.8%10.1%

Return vs Industry: BP8 exceeded the Australian Biotechs industry which returned -43.8% over the past year.

Return vs Market: BP8 underperformed the Australian Market which returned 10.1% over the past year.

Price Volatility

Is BP8's price volatile compared to industry and market?
BP8 volatility
BP8 Average Weekly Movement59.0%
Biotechs Industry Average Movement10.8%
Market Average Movement10.7%
10% most volatile stocks in AU Market17.8%
10% least volatile stocks in AU Market4.6%

Stable Share Price: BP8's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: BP8's weekly volatility has increased from 51% to 59% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984n/aMatthew Leonardbphglobal.com

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries.

BPH Global Ltd Fundamentals Summary

How do BPH Global's earnings and revenue compare to its market cap?
BP8 fundamental statistics
Market capAU$4.71m
Earnings (TTM)-AU$2.16m
Revenue (TTM)AU$1.73m
2.7x
P/S Ratio
-2.2x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BP8 income statement (TTM)
RevenueAU$1.73m
Cost of RevenueAU$1.76m
Gross Profit-AU$35.79k
Other ExpensesAU$2.12m
Earnings-AU$2.16m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.00092
Gross Margin-2.07%
Net Profit Margin-124.84%
Debt/Equity Ratio-70.7%

How did BP8 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/26 03:14
End of Day Share Price 2026/04/24 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BPH Global Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.